Jeff Nelson
Chief Operating Officer at MILESTONE PHARMACEUTICALS INC.
Net worth: - $ as of 31/03/2024
Profile
Jeff Nelson is currently the Chief Operating Officer at Milestone Pharmaceuticals, Inc. He previously worked as the Vice President-Program Management at Oncotelic Therapeutics, Inc. from 2015 to 2017, and as the Head-Clinical Operations at Axsome Therapeutics, Inc. from 2014 to 2015.
Mr. Nelson completed his undergraduate degree at Brandeis University in 2003.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 16/02/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Jeff Nelson active positions
| Companies | Position | Start |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Chief Operating Officer | 01/06/2020 |
Former positions of Jeff Nelson
| Companies | Position | End |
|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2017 |
| AXSOME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2015 |
Training of Jeff Nelson
| Brandeis University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Health Technology |
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| AXSOME THERAPEUTICS, INC. | Health Technology |
- Stock Market
- Insiders
- Jeff Nelson